4967 — Kobayashi Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMid CapHigh Flyer

Annual income statement for Kobayashi Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	150,514	155,252	166,258	173,455	165,600
Cost of Revenue
Gross Profit	85,266	88,774	92,331	96,376	87,603
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	125,859	129,646	139,912	147,823	154,271
Operating Profit	24,655	25,606	26,346	25,632	11,329
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	26,635	27,636	27,950	27,559	13,914
Provision for Income Taxes
Net Income After Taxes	19,205	19,716	20,023	20,338	10,072
Minority Interest
Net Income Before Extraordinary Items
Net Income	19,205	19,716	20,023	20,338	10,068
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	19,205	19,715	20,022	20,338	10,067
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	262	267	276	285	287
Dividends per Share